Sold some from my Gilead (GILD) position today. Shares jumped on report that Gilead's AIDS drugs are better than Epzicom from GlaxoSmithKline. Good. But I still in doubt about long term perspectives of the company. No visible pipeline for now.
Full disclosure: at the time of publication author had long position in Gilead Sciences. Positions can change at any time.
Disclaimer: This article is not intended as an investment advice. Every person should make her/his own investment decisions based on all available information and advice from her/his own financial advisor.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment